Although MDM2 gene amplification has been reported in luminal breast cancers (Wege et al. 2022), the role of epitranscriptomic mechanisms in MDM2 regulation remains largely unexplored in breast cancers. This evidence concerns the gene MDM2 and breast carcinoma.